Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia 5-09-2023, 17:00

Maha Energy enters into a definitive agreement regarding 6-02-2023, 18:10

Freddie Mac Announces Release Date for Fourth Quarter and 13-02-2023, 23:40